H.R. 3808 · 117th Congress · House

Medicare IVIG Access Enhancement Act

Active· Referred to the Subcommittee on Health.
Introduced
Jun 11, 21
Passed House
Pending
Passed Senate
Pending
Sent to President
Pending
Signed into Law
Pending

Executive Summary

Medicare IVIG Access Enhancement Act

This bill requires the Centers for Medicare & Medicaid Services to establish a five-year demonstration project to evaluate the benefits of providing Medicare coverage and payment for items and services needed for the in-home administration of intravenous immune globulin to treat chronic inflammatory demyelinating polyneuropathy or multifocal motor neuropathy. Beneficiary participation shall be voluntary.

Action Timeline

6
  1. JUN 14, 2021•Committee

    Referred to the Subcommittee on Health.

  2. JUN 11, 2021•IntroReferral

    Introduced in House

  3. JUN 11, 2021•IntroReferral

    Introduced in House

  4. JUN 11, 2021•IntroReferral

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

  5. JUN 11, 2021•IntroReferral

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

  6. JUN 11, 2021•Committee

    Referred to the Subcommittee on Health.

Committees

4

Health Subcommittee

hsif14

Referred: Jun 14, 2021

Active

Health Subcommittee

hswm02

Referred: Jun 11, 2021

Active

Ways and Means Committee

hswm00

Referred: Jun 11, 2021

Active

Energy and Commerce Committee

hsif00

Referred: Jun 11, 2021

Active